MYUNGMOON Pharm (017180.KS) Earnings Analysis

MYUNGMOON Pharm (017180.KS) has no confirmed upcoming earnings date. Trailing P/E 15.18.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 017180.KS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 017180.KS. This page updates as the calendar is published.

017180.KS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-12-3017.62 KRWn/an/an/a
2025-09-30-17 KRWn/an/an/a
2025-06-30103 KRWn/an/an/a
2025-05-15-57.99973 KRWn/an/an/a
2025-02-1915.2 KRWn/an/an/a
2024-11-14-23.99999 KRWn/an/an/a
2024-08-14-45.76631 KRWn/an/an/a

017180.KS valuation and analyst view

Trailing P/E15.18
Trailing EPS90.505 KRW
Price / book0.42
Dividend yield0.00%
Market cap40.78B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is MYUNGMOON Pharm (017180.KS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 017180.KS. This page updates as the calendar is published.

Did 017180.KS beat earnings last quarter?

Consensus estimate data was not available for 017180.KS's 2025-12-30 report.

What is 017180.KS's current P/E ratio and EPS?

017180.KS trades at a trailing P/E of 15.18 on trailing EPS of 90.5049284991225 KRW.

What do analysts rate 017180.KS?

017180.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.